BardyDx: Hillrom Provides Update on Planned Acquisition of Bardy Diagnostics, Inc.
Hillrom (NYSE: HRC) today provided an update on its planned acquisition of Bardy Diagnostics, Inc. (BardyDx), which it previously announced on January 19, 2021.
Read full article »
CEO
BardyDx develops and commercializes non-invasive ambulatory cardiac monitoring and arrhythmia detection devices for physicians.
Read more